UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 203

Sortiert nach

Reclassification of Clostridium difficile as Clostridioides difficile (Hall and O’Toole 1935) Prévot 1938

Anaerobe, 2016-08, Vol.40, p.95-99

2016

Link zum Volltext

Verfügbarkeit prüfen

Description of two novel members of the family Erysipelotrichaceae: Ileibacterium valens gen. nov., sp. nov. and Dubosiella newyorkensis, gen. nov., sp. nov., from the murine intestine, and emendation to the description of Faecalibacterium rodentium

International journal of systematic and evolutionary microbiology, 2017-05, Vol.67 (5), p.1247-1254

2017

Link zum Volltext

Verfügbarkeit prüfen

Bacteriology of Moderate-to-Severe Diabetic Foot Infections and In Vitro Activity of Antimicrobial Agents

Journal of Clinical Microbiology, 2007-09, Vol.45 (9), p.2819-2828

2007

Link zum Volltext

Verfügbarkeit prüfen

Comparative Susceptibilities to Fidaxomicin (OPT-80) of Isolates Collected at Baseline, Recurrence, and Failure from Patients in Two Phase III Trials of Fidaxomicin against Clostridium difficile Infection

Antimicrobial Agents and Chemotherapy, 2011-11, Vol.55 (11), p.5194-5199

2011

Link zum Volltext

Verfügbarkeit prüfen

Comparative In Vitro Activities of SMT19969, a New Antimicrobial Agent, against Clostridium difficile and 350 Gram-Positive and Gram-Negative Aerobic and Anaerobic Intestinal Flora Isolates

Antimicrobial Agents and Chemotherapy, 2013-10, Vol.57 (10), p.4872-4876

2013

Link zum Volltext

Verfügbarkeit prüfen

In Vitro Activity of Biapenem plus RPX7009, a Carbapenem Combined with a Serine β-Lactamase Inhibitor, against Anaerobic Bacteria

Antimicrobial Agents and Chemotherapy, 2013-06, Vol.57 (6), p.2620-2630

2013

Link zum Volltext

Verfügbarkeit prüfen

Comparative In Vitro Activities of SMT19969, a New Antimicrobial Agent, against 162 Strains from 35 Less Frequently Recovered Intestinal Clostridium Species: Implications for Clostridium difficile Recurrence

Antimicrobial Agents and Chemotherapy, 2014-02, Vol.58 (2), p.1187-1191

2014

Link zum Volltext

Verfügbarkeit prüfen

Comparative In Vitro Activities of LFF571 against Clostridium difficile and 630 Other Intestinal Strains of Aerobic and Anaerobic Bacteria

Antimicrobial Agents and Chemotherapy, 2012-05, Vol.56 (5), p.2493-2503

2012

Link zum Volltext

Verfügbarkeit prüfen

Clostridium difficile Infection Among US Emergency Department Patients With Diarrhea and No Vomiting

Annals of emergency medicine, 2017-07, Vol.70 (1), p.19-27.e4

2017

Link zum Volltext

Verfügbarkeit prüfen

Lactobacillus Species: Taxonomic Complexity and Controversial Susceptibilities

Clinical infectious diseases, 2015-05, Vol.60 (suppl_2), p.S98-S107

2015

Link zum Volltext

Verfügbarkeit prüfen

In Vitro Activities of CB-183,315, Vancomycin, and Metronidazole against 556 Strains of Clostridium difficile, 445 Other Intestinal Anaerobes, and 56 Enterobacteriaceae Species

Antimicrobial Agents and Chemotherapy, 2012-03, Vol.56 (3), p.1613-1615

2012

Link zum Volltext

Verfügbarkeit prüfen

Update on the Taxonomy and Clinical Aspects of the Genus Fusobacterium

Clinical infectious diseases, 2002-09, Vol.35 (Supplement-1), p.S22-S27

CITRON, Diane M

2002

Link zum Volltext

Verfügbarkeit prüfen

In Vitro Activity of Ceftazidime-NXL104 against 396 Strains of β-Lactamase-Producing Anaerobes

Antimicrobial Agents and Chemotherapy, 2011-07, Vol.55 (7), p.3616-3620

2011

Link zum Volltext

Verfügbarkeit prüfen

central role for venom in predation by Varanus komodoensis (Komodo Dragon) and the extinct giant Varanus (Megalania) priscus

Proceedings of the National Academy of Sciences - PNAS, 2009-06, Vol.106 (22), p.8969-8974

2009

Link zum Volltext

Verfügbarkeit prüfen

Evaluation of Cycloserine-Cefoxitin Fructose Agar (CCFA), CCFA with Horse Blood and Taurocholate, and Cycloserine-Cefoxitin Mannitol Broth with Taurocholate and Lysozyme for Recovery of Clostridium difficile Isolates from Fecal Samples

Journal of Clinical Microbiology, 2013-09, Vol.51 (9), p.3094-3096

2013

Link zum Volltext

Verfügbarkeit prüfen

In Vitro Activity of TD-1792, a Multivalent Glycopeptide-Cephalosporin Antibiotic, against 377 Strains of Anaerobic Bacteria and 34 Strains of Corynebacterium Species

Antimicrobial Agents and Chemotherapy, 2012-04, Vol.56 (4), p.2194-2197

2012

Link zum Volltext

Verfügbarkeit prüfen

Comparative In Vitro Activities of GSK2251052, a Novel Boron-Containing Leucyl-tRNA Synthetase Inhibitor, against 916 Anaerobic Organisms

Antimicrobial Agents and Chemotherapy, 2013-05, Vol.57 (5), p.2401-2404

2013

Link zum Volltext

Verfügbarkeit prüfen

Clinical Presentation and Bacteriologic Analysis of Infected Human Bites in Patients Presenting to Emergency Departments

Clinical infectious diseases, 2003-12, Vol.37 (11), p.1481-1489

2003

Link zum Volltext

Verfügbarkeit prüfen

In Vitro Activities of Daptomycin, Ciprofloxacin, and Other Antimicrobial Agents against the Cells and Spores of Clinical Isolates of Bacillus Species

Journal of Clinical Microbiology, 2006-10, Vol.44 (10), p.3814-3818

2006

Link zum Volltext

Verfügbarkeit prüfen

MBX-500, a Hybrid Antibiotic with In Vitro and In Vivo Efficacy against Toxigenic Clostridium difficile

Antimicrobial Agents and Chemotherapy, 2012-09, Vol.56 (9), p.4786-4792

2012

Link zum Volltext

Verfügbarkeit prüfen

Ceftaroline versus Isolates from Animal Bite Wounds: Comparative In Vitro Activities against 243 Isolates, Including 156 Pasteurella Species Isolates

Antimicrobial Agents and Chemotherapy, 2012-12, Vol.56 (12), p.6319-6323

2012

Link zum Volltext

Verfügbarkeit prüfen

Desulfovibrio desulfuricans Bacteremia and Review of Human Desulfovibrio Infections

Journal of Clinical Microbiology, 2003-06, Vol.41 (6), p.2752-2754

2003

Link zum Volltext

Verfügbarkeit prüfen

Biochemical Differentiation and Comparison of Desulfovibrio Species and Other Phenotypically Similar Genera

Journal of Clinical Microbiology, 2005-08, Vol.43 (8), p.4041-4045

2005

Link zum Volltext

Verfügbarkeit prüfen

In Vitro Activities of the New Semisynthetic Glycopeptide Telavancin (TD-6424), Vancomycin, Daptomycin, Linezolid, and Four Comparator Agents against Anaerobic Gram-Positive Species and Corynebacterium spp

Antimicrobial Agents and Chemotherapy, 2004-06, Vol.48 (6), p.2149-2152

2004

Link zum Volltext

Verfügbarkeit prüfen

In Vitro Activities of Dalbavancin and Nine Comparator Agents against Anaerobic Gram-Positive Species and Corynebacteria

Antimicrobial Agents and Chemotherapy, 2003-06, Vol.47 (6), p.1968-1971

2003

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 203

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(191)
Mit Volltextzugriff
(191)

Publikationsform

Sprache

Englisch
(203)
Japanisch
(18)

Erscheinungsjahr

n.n

Thema

Science & Technology
(168)
Life Sciences & Biomedicine
(167)
Microbiology
(153)
Humans
(137)
Biological And Medical Sciences
(108)
Medical Sciences
(98)
Microbial Sensitivity Tests
(86)
Anti-Bacterial Agents - Pharmacology
(77)
Pharmacology. Drug Treatments
(71)
Antibiotics. Antiinfectious Agents. Antiparasitic Agents
(70)
Pharmacology & Pharmacy
(70)
Infectious Diseases
(67)
Bacteria, Anaerobic - Drug Effects
(60)
Susceptibility
(53)
Antibacterial Agents
(43)
Anti-Bacterial Agents
(36)
Bacteria, Anaerobic
(35)
Bacteria, Anaerobic - Isolation & Purification
(34)
Bacteriology
(34)
Animals
(33)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Reclassification of Clostridium difficile as Clostridioides difficile (Hall and O’Toole 1935) Prévot 1938

Description of two novel members of the family Erysipelotrichaceae: Ileibacterium valens gen. nov., sp. nov. and Dubosiella newyorkensis, gen. nov., sp. nov., from the murine intestine, and emendation to the description of Faecalibacterium rodentium

Bacteriology of Moderate-to-Severe Diabetic Foot Infections and In Vitro Activity of Antimicrobial Agents

Comparative Susceptibilities to Fidaxomicin (OPT-80) of Isolates Collected at Baseline, Recurrence, and Failure from Patients in Two Phase III Trials of Fidaxomicin against Clostridium difficile Infection

Comparative In Vitro Activities of SMT19969, a New Antimicrobial Agent, against Clostridium difficile and 350 Gram-Positive and Gram-Negative Aerobic and Anaerobic Intestinal Flora Isolates

In Vitro Activity of Biapenem plus RPX7009, a Carbapenem Combined with a Serine β-Lactamase Inhibitor, against Anaerobic Bacteria

Comparative In Vitro Activities of SMT19969, a New Antimicrobial Agent, against 162 Strains from 35 Less Frequently Recovered Intestinal Clostridium Species: Implications for Clostridium difficile Recurrence

Comparative In Vitro Activities of LFF571 against Clostridium difficile and 630 Other Intestinal Strains of Aerobic and Anaerobic Bacteria

Clostridium difficile Infection Among US Emergency Department Patients With Diarrhea and No Vomiting

Lactobacillus Species: Taxonomic Complexity and Controversial Susceptibilities

In Vitro Activities of CB-183,315, Vancomycin, and Metronidazole against 556 Strains of Clostridium difficile, 445 Other Intestinal Anaerobes, and 56 Enterobacteriaceae Species

Update on the Taxonomy and Clinical Aspects of the Genus Fusobacterium

In Vitro Activity of Ceftazidime-NXL104 against 396 Strains of β-Lactamase-Producing Anaerobes

central role for venom in predation by Varanus komodoensis (Komodo Dragon) and the extinct giant Varanus (Megalania) priscus

Evaluation of Cycloserine-Cefoxitin Fructose Agar (CCFA), CCFA with Horse Blood and Taurocholate, and Cycloserine-Cefoxitin Mannitol Broth with Taurocholate and Lysozyme for Recovery of Clostridium difficile Isolates from Fecal Samples

In Vitro Activity of TD-1792, a Multivalent Glycopeptide-Cephalosporin Antibiotic, against 377 Strains of Anaerobic Bacteria and 34 Strains of Corynebacterium Species

Comparative In Vitro Activities of GSK2251052, a Novel Boron-Containing Leucyl-tRNA Synthetase Inhibitor, against 916 Anaerobic Organisms

Clinical Presentation and Bacteriologic Analysis of Infected Human Bites in Patients Presenting to Emergency Departments

In Vitro Activities of Daptomycin, Ciprofloxacin, and Other Antimicrobial Agents against the Cells and Spores of Clinical Isolates of Bacillus Species

MBX-500, a Hybrid Antibiotic with In Vitro and In Vivo Efficacy against Toxigenic Clostridium difficile

Ceftaroline versus Isolates from Animal Bite Wounds: Comparative In Vitro Activities against 243 Isolates, Including 156 Pasteurella Species Isolates

Desulfovibrio desulfuricans Bacteremia and Review of Human Desulfovibrio Infections

Biochemical Differentiation and Comparison of Desulfovibrio Species and Other Phenotypically Similar Genera

In Vitro Activities of the New Semisynthetic Glycopeptide Telavancin (TD-6424), Vancomycin, Daptomycin, Linezolid, and Four Comparator Agents against Anaerobic Gram-Positive Species and Corynebacterium spp

In Vitro Activities of Dalbavancin and Nine Comparator Agents against Anaerobic Gram-Positive Species and Corynebacteria

Suchergebnisse filtern